Versant Venture Capital VI, L.P., 10% Owner at Monte Rosa Therapeutics, Inc. (GLUE), sold 2,265,132 shares at $6.53 ($14.8M) on 2024-09-20, disclosed to the SEC on 2024-09-24.
Open-market sale of $14.8M GLUE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.53 | 1,132,566 | $7.4M | 50.0% |
| 2 | $6.53 | 1,132,566 | $7.4M | 50.0% |
| Total | $6.53 avg | 2,265,132 | $14.8M | 100% |
| Filing → |
| GLUE | SELL | 2024-10-30 | $2.8M | — | Filing → |
| TPST | SELL | 2024-08-12 | $1.4M | — | Filing → |
| OYST | SELL | 2021-10-20 | $16.3M | — | Filing → |